The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities - Top-Institutions - MDSpire

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

  • By

  • Zhennan Ma

  • Xiuqing Gong

  • Fuquan Liu

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

  • #2

    National Surgical Adjuvant Breast and Bowel Project (NSABP)
    National Surgical Adjuvant Breast and Bowel Project (NSABP)

    Pittsburgh, Pennsylvania

    Key Differentiators

    • Oncology

  • #3

    BC Cancer
    BC Cancer

    Vancouver, British Columbia

    Key Differentiators

    • Oncology

  • #4

    Mount Sinai
    Mount Sinai

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

  • by Zhennan Ma, Xiuqing Gong, Fuquan Liu

  • May 28, 2026

Related Content

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen